Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders. - Malherbe JAJ; Misko J; Jayawardena NK; Rawlins MDM; Manning L; Purtill D (Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2026)